Outsourcing in Clinical Trials USA
The Annual OCT USA will take place virtually this year. Meet up with Executive Director, Business Development Megan O’Keefe at the 12th edition of OCT USA to engage in numerous panels, debates, interviews, and case-study presentations. The program will feature the latest in studies, technologies, and providers to help set your trials apart. We look forward to connecting with you virtually – for more information or to register, click the link below.
30 September - 1 October 2020
Panel Discussion at OCT USA
In addition to our OCT USA virtual exhibit, we will be holding Decentralized Trials: A Real-World Example, a panel discussion on an exciting new breakthrough in clinical trial management. Tune in at 12:55 PM ET to hear the latest insights from our VP of Oncology Drug Development, Andrew Zupnick, PhD, our Global Head of Clinical Development, Keya Watkins, and our moderator, Catalyst's Chief Strategy Officer, Melissa Church.
1 October 2020 | 12:55 PM ET
PharmaSUG Single Day Event
While we respect PharmaSUG's decision to cancel their annual conference this year to help ensure the health and safety of all involved, we are thrilled to be sponsoring their single-day virtual event. Join us this fall as we hear from renowned speakers in the industry, learn the latest tips and tricks, and address issues and solutions with industry experts. To learn more or register, click the links below.
23 October 2020
NEXT Global Speaking Session
The current clinical trial landscape challenges operations teams with increasing workloads but fewer resources. In "The Value of a Unified Platform for CTMS," Medidata Solutions' VP of Product, Martin Dowdall, along with Catalyst's Global Head of Clinical Development, Keya Watkins, discuss the challenges our team has experienced with complex early phase oncology studies. Further, they discuss why we chose Rave CTMS+eTMF on the Medidata Clinical Cloud to help their team attain operational success and to deliver on their strategic goals, enabling them to increase both efficiency and effectiveness.
27 October 2020
The Society for Immunotherapy of Cancer 2020 conference will be held virtually this year. The largest conference completely focused on cancer immunotherapy brings together cancer immunotherapy fields to advance science, discover breakthroughs, and educate the world on cancer therapies. The conference boasts high attendance rates featuring industry representatives seeking an educational and interactive environment with the sole focus of improving outcomes for all cancer patients. To learn more about SITC or register, click the buttons below.
10 November - 15 November 2020
The 62 annual ASH meeting exposition will take place this year at the San Diego Convention Center in San Diego, CA. In light of health concerns and travel restrictions, ASH is also offering the option to attend virtually. Catalyst will be exhibiting at the premier event in malignant and non-malignant hematology. We look forward to connecting with you at the world’s most comprehensive hematology event of the year, and welcome the opportunity to learn invaluable information and gain priceless experience at the 62 annual meeting. For more information on ASH, or to schedule a meeting with Catalyst, click the buttons below.
5 December - 8 December 2020
San Diego, CA USA or Virtual